BioNexus Gene Lab Corp. (BGLC) NASDAQ
2.21
-0.0617(-2.72%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.21
-0.0617(-2.72%)
Currency In USD
| Market Cap | 4.99M |
| Enterprise Value | 822,304 |
| P/E Ratio | -1.73 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 0.42 |
| Price/Book Ratio | 0.58 |
| Enterprise/Revenue | 0.13 |
| Enterprise/EBITDA | -0.58 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0.24 |
| Operating Margin | -0.25 |
| Return On Assets | -0.3 |
| Return On Equity | -0.3 |
| Revenue | 9.51M |
| Revenue/Share | 5.27 |
| Gross Profit | 1.29M |
| EBITDA | -1.42M |
| Net Income | -1.6M |
| Diluted EPS | -0.9 |
| Total Cash | 2.89M |
| Total Cash/Share | 1.61 |
| Total Debt | 183,746 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 8.3 |
| Book Value Per Share | 3.79 |
| 52-Week Change | -6.03 |
| 52-Week High | 15.6 |
| 52-Week Low | 1.92 |
| Moving Average 50 Days | 2.44 |
| Moving Average 200 Days | 4.28 |
| Average Volume | 20,800 |
| Shares Outstanding | 1.8M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 07, 2025 |